Search
for
Sort by
Research 151–180 of 1000+
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Nanostructured lipid carriers promote percutaneous absorption and hair follicle targeting of tofacitinib for treating alopecia areata
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Reversal of alopecia areata, osteoporosis follow treatment with activation of Tgr5 in mice
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- Alopecia areata: current concepts
- Alopecia Areata and Atopic Dermatitis: Common Mechanisms and Emerging Therapeutics
- Circulating MicroRNA Signatures in Severe Alopecia Areata: Diagnostic Discrimination, Pathway Analysis, and Therapeutic Implications
- DISRUPTION OF HAIR FOLLICLE IMMUNE PRIVILEGE IN ALOPECIA AREATA: ENIGMATIC MECHANISMS AND EMERGING CONCEPTS
- Recent Advances in Drug Development for Hair Loss
- Integration Analysis of Transcriptome Sequencing and Whole-Genome Resequencing Reveal Wool Quality-Associated Key Genes in Zhexi Angora Rabbits
- Human umbilical cord mesenchymal stem cell treatment alleviates symptoms in an atopic dermatitis-like mouse model
- Psychological Stress-Induced Pathogenesis of Alopecia Areata: Autoimmune and Apoptotic Pathways
- Unexpected Effect of Baricitinib Use: Observation of a Case of Hypertrichosis
- Comprehensive single-cell transcriptomic profiling of the scalp from patients with moderate-to-severe alopecia areata
- Autoinmune Alopecia/Alopecia Areata
- Efficacy and safety of baricitinib in patients with alopecia areata: evidence to date
- Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata
- CXCL12 inhibits hair growth through CXCR4
- Alopecia areata – Current understanding and management
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- Insights from Tandem Mass Tag (TMT) Proteomic Analysis on Protein Network Modification in Control of Yak Hair Follicle Cycle
- Vitiligo—Current Treatment Options and Future Perspectives
- Overlapping features of atopic dermatitis and alopecia areata: from pathogenesis to treatment
- Immune niches for hair follicle development and homeostasis
- Baricitinib Attenuates IFN-γ and Polyinosinic:polycytidylic Acid‒Induced Mitochondrial Damage and Inflammasome Activation in Human Keratinocytes
- FDA approval of Deuruxolitinib: A New Treatment Option for Severe Alopecia Areata
- Cell‐free transcriptomic profiles and mechanism insights in female androgenetic alopecia
- Alopecia areata – Aktuelles Verständnis und Management